France Bed Holdings Co.,Ltd.

TSE:7840 Voorraadrapport

Marktkapitalisatie: JP¥43.0b

France Bed HoldingsLtd Inkomsten in het verleden

Verleden criteriumcontroles 5/6

France Bed HoldingsLtd has been growing earnings at an average annual rate of 6.9%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 3.4% per year. France Bed HoldingsLtd's return on equity is 8.3%, and it has net margins of 5.3%.

Belangrijke informatie

6.9%

Groei van de winst

9.1%

Groei van de winst per aandeel

Healthcare Groei van de industrie7.9%
Inkomstengroei3.4%
Rendement op eigen vermogen8.3%
Nettomarge5.3%
Volgende winstupdate08 Nov 2024

Recente prestatie-updates uit het verleden

Recent updates

France Bed HoldingsLtd (TSE:7840) Will Pay A Larger Dividend Than Last Year At ¥21.00

Mar 11
France Bed HoldingsLtd (TSE:7840) Will Pay A Larger Dividend Than Last Year At ¥21.00

France Bed HoldingsLtd (TSE:7840) Is Increasing Its Dividend To ¥21.00

Feb 26
France Bed HoldingsLtd (TSE:7840) Is Increasing Its Dividend To ¥21.00

Opbrengsten en kosten

Hoe France Bed HoldingsLtd geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

TSE:7840 Opbrengsten, kosten en inkomsten (JPY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 2459,9973,17127,6140
31 Mar 2459,1513,13427,3020
31 Dec 2358,7052,63627,2880
30 Sep 2358,7002,71227,0930
30 Jun 2358,7822,77426,8610
31 Mar 2358,5782,70226,7130
31 Dec 2257,5542,54426,3930
30 Sep 2256,6642,49126,0210
30 Jun 2255,3922,34925,6450
31 Mar 2254,3982,55725,0810
31 Dec 2154,1132,62524,7630
30 Sep 2154,0102,74924,4990
30 Jun 2154,0512,77824,2900
31 Mar 2152,4302,29523,7920
31 Dec 2051,2051,95823,3020
30 Sep 2050,4991,70523,1180
30 Jun 2051,1941,54523,1180
31 Mar 2052,4301,52023,4250
31 Dec 1952,7552,91023,4930
30 Sep 1952,7972,57623,4130
30 Jun 1951,6462,42523,2640
31 Mar 1951,7642,59923,1280
31 Dec 1852,3331,57923,1330
30 Sep 1852,2071,74423,0280
30 Jun 1852,5291,90022,9220
31 Mar 1852,4101,80622,8280
31 Dec 1752,3062,20022,7900
30 Sep 1752,2412,09722,8590
30 Jun 1752,0511,88722,7980
31 Mar 1752,1261,93122,7560
31 Dec 1652,0081,20222,7030
30 Sep 1652,3771,33122,5640
30 Jun 1652,5491,38422,4400
31 Mar 1652,6441,40222,3100
31 Dec 1552,8601,36422,1950
30 Sep 1552,6091,18822,1920
30 Jun 1552,0771,03322,2410
31 Mar 1551,90790422,2910
31 Dec 1453,4221,00422,3960
30 Sep 1454,2031,14322,3040
30 Jun 1454,6081,31522,0730
31 Mar 1454,8911,39721,9390
31 Dec 1352,7281,28821,4790

Kwaliteitswinsten: 7840 has high quality earnings.

Groeiende winstmarge: 7840's current net profit margins (5.3%) are higher than last year (4.7%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: 7840's earnings have grown by 6.9% per year over the past 5 years.

Versnelling van de groei: 7840's earnings growth over the past year (14.3%) exceeds its 5-year average (6.9% per year).

Winst versus industrie: 7840 earnings growth over the past year (14.3%) exceeded the Healthcare industry 9.6%.

Rendement op eigen vermogen

Hoge ROE: 7840's Return on Equity (8.3%) is considered low.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y